On Monday, Amazon introduced a new feature that allows anyone to design merchandise using AI, posing an expanded challenge to online merch platforms like Redbubble, Bonfire, Spring, Fourthwall, and ...

Getting email personalization right — and, more importantly, implementing it at scale — is what can really move the needle for ecommerce brands that are struggling to drive decent ROI from their email ...

Threat actors in Latin America have begun to use AI agents to facilitate their entire attack chains, from assisting with initial access to generating penetration tools on the fly — and organizations ...

Altria is the dominant cigarette maker in the US. Its Marlboro brand holds a 40% share per Euromonitor, towering above the 13% held by the next-largest marker. The US market size has remained around ...

Firefly custom models analyze your assets to preserve character designs and emulate illustration and photography styles. Firefly custom models analyze your assets to preserve character designs and ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A new economic report suggests ...

Apple is improving music discovery with a new feature in the iOS 26.4 beta: Playlist Playground. For those curious about this update, it's an AI-driven addition to Apple Music where users can now ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...